|
1）Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-305
|
|
|
|
2）伊藤 裕. メタボリックシンドロームと慢性腎臓病（CKD）．日本内科学会雑誌. 2014; 103: 710-6
|
|
|
|
|
|
3）Qureshi AR, Alvestrand A, Danielsson A, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int. 1998; 53: 773-82
|
|
|
|
|
|
4）脇野 修, 伊藤 裕. メタボリックドミノと心腎連関. 実験医学. 2009; 17: 1785
|
|
|
|
|
|
5）Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. Diabetes Metab. 2004; 30: 487-96
|
|
|
|
|
|
6）Mitsuishi M, Miyashita K, Muraki A, et al. Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control. Diabetes. 2009; 58: 710-7
|
|
|
|
|
|
7）McIntyre CW, Selby NM, Sigrist M, et al. Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease. Nephrol Dial Transplant. 2006; 21: 2210-6
|
|
|
|
|
|
8）Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology. 2008; 23: 160-70
|
|
|
|
|
|
9）Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010; 91: 1128s-1132s
|
|
|
|
|
|
10）Mitch WE, Medina R, Grieber S, et al. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest. 1994; 93: 2127-33
|
|
|
|
|
|
11）Bailey JL, Zheng B, Hu Z, et al. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol. 2006; 17: 1388-94
|
|
|
|
|
|
12）Yoshida T, Galvez S, Tiwari S, et al. Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration. J Biol Chem. 2013; 288: 23823-32
|
|
|
|
|
|
13）Wang XH, Du J, Klein JD, et al. Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. Kidney Int. 2009; 76: 751-9
|
|
|
|
|
|
14）Chen Y, Sood S, Biada J, et al. Increased workload fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle. Kidney Int. 2008; 73: 848-55
|
|
|
|
|
|
15）Fried LF, Lee JS, Shlipak M, et al. Chronic kidney disease and functional limitation in older people: health, aging and body composition study. J Am Geriatr Soc. 2006; 54: 750-6
|
|
|
|
|
|
16）Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005; 293: 1737-45
|
|
|
|
|
|
17）Beddhu S, Baird BC, Zitterkoph J, et al. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009; 4: 1901-6
|
|
|
|
|
|
18）Tamaki M, Miyashita K, Wakino S, et al. Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase. Kidney Int. 2014; 85: 1330-9
|
|
|
|
|
|
19）Castaneda C, Gordon PL, Parker RC, et al. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis. 2004; 43: 607-16
|
|
|
|
|
|
20）Storer TW, Casaburi R, Sawelson S, et al. Endurance exercise training during haemodialysis improves strength, power, fatigability and physical performance in maintenance haemodialysis patients. Nephrol Dial Transplant. 2005; 20: 1429-37
|
|
|
|
|
|
21）Johansen KL, Painter P. Exercise in individuals with CKD. Am J Kidney Dis. 2012; 59: 126-34
|
|
|
|
|
|
22）Johansen KL. Exercise and chronic kidney disease: current recommendations. Sports Med. 2005; 35: 485-99
|
|
|
|
|
|
23）Macdonald JH, Marcora SM, Jibani MM, et al. Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study. Nephron Clin Pract. 2007; 106: c125-35
|
|
|
|
|
|
24）Moinuddin I, Leehey DJ. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis. 2008; 15: 83-96
|
|
|
|
|
|
25）Johansen KL. Exercise in the end-stage renal disease population. J Am Soc Nephrol. 2007; 18: 1845-54
|
|
|
|
|
|
26）Howden EJ, Fassett RG, Isbel NM, et al. Exercise training in chronic kidney disease patients. Sports Med. 2012; 42: 473-88
|
|
|
|
|
|
27）Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014; 10: 504-16
|
|
|
|
|